Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder. (August 2021)
- Record Type:
- Journal Article
- Title:
- Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder. (August 2021)
- Main Title:
- Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder
- Authors:
- Simpson, Helen B.
Foa, Edna B.
Wheaton, Michael G.
Gallagher, Thea
Gershkovich, Marina
Schmidt, Andrew B.
Huppert, Jonathan D.
Campeas, Raphael B.
Imms, Patricia A.
Cahill, Shawn P.
DiChiara, Christina
Tsao, Steven D.
Puliafico, Anthony C.
Chazin, Daniel
Asnaani, Anu
Moore, Kelly
Tyler, Jeremy
Steinman, Shari A.
Sanchez-LaCay, Arturo
Capaldi, Sandy
Snorrason, Ivar
Turk-Karan, Elizabeth
Vermes, Donna
Kalanthroff, Eyal
Pinto, Anthony
Hahn, Chang-Gyu
Xu, Bin
Van Meter, Page E.
Katechis, Martha
Scodes, Jennifer
Wang, Yuanjia
… (more) - Abstract:
- Abstract: Practice guidelines for adults with obsessive-compulsive disorder (OCD) recommend augmenting serotonin reuptake inhibitors (SRIs) with exposure and ritual prevention (EX/RP). However, fewer than half of patients remit after a standard 17-session EX/RP course. We studied whether extending the course increased overall remission rates and which patient factors predicted remission. Participants were 137 adults with clinically significant OCD (Yale-Brown Obsessive Compulsive Scale [Y-BOCS] score ≥18) despite an adequate SRI trial (≥12 weeks). Continuing their SRI, patients received 17 sessions of twice-weekly EX/RP (standard course). Patients who did not remit (Y-BOCS ≤12) received up to 8 additional sessions (extended course). Of 137 entrants, 123 completed treatment: 49 (35.8%) remitted with the standard course and another 46 (33.6%) with the extended course. Poorer patient homework adherence, more Obsessive-Compulsive Personality Disorder (OCPD) traits, and the Brain-Derived Neurotrophic Factor (BDNF) Val66MET genotype were associated with lower odds of standard course remission. Only homework adherence differentiated non-remitters from extended course remitters. Extending the EX/RP course from 17 to 25 sessions enabled many (69.3%) OCD patients on SRIs to achieve remission. Although behavioral (patient homework adherence), psychological (OCPD traits), and biological (BDNF genotype) factors influenced odds of EX/RP remission, homework adherence was the most potentAbstract: Practice guidelines for adults with obsessive-compulsive disorder (OCD) recommend augmenting serotonin reuptake inhibitors (SRIs) with exposure and ritual prevention (EX/RP). However, fewer than half of patients remit after a standard 17-session EX/RP course. We studied whether extending the course increased overall remission rates and which patient factors predicted remission. Participants were 137 adults with clinically significant OCD (Yale-Brown Obsessive Compulsive Scale [Y-BOCS] score ≥18) despite an adequate SRI trial (≥12 weeks). Continuing their SRI, patients received 17 sessions of twice-weekly EX/RP (standard course). Patients who did not remit (Y-BOCS ≤12) received up to 8 additional sessions (extended course). Of 137 entrants, 123 completed treatment: 49 (35.8%) remitted with the standard course and another 46 (33.6%) with the extended course. Poorer patient homework adherence, more Obsessive-Compulsive Personality Disorder (OCPD) traits, and the Brain-Derived Neurotrophic Factor (BDNF) Val66MET genotype were associated with lower odds of standard course remission. Only homework adherence differentiated non-remitters from extended course remitters. Extending the EX/RP course from 17 to 25 sessions enabled many (69.3%) OCD patients on SRIs to achieve remission. Although behavioral (patient homework adherence), psychological (OCPD traits), and biological (BDNF genotype) factors influenced odds of EX/RP remission, homework adherence was the most potent patient factor overall. Highlights: We tested EX/RP as an SRI augmentation strategy for adults with OCD. Extending EX/RP from 17 to 25 sessions of EX/RP enabled 69.3% of patients to achieve remission. Patient adherence, OCPD traits, and BDNF genotype influenced the odds and timing of remission. … (more)
- Is Part Of:
- Behaviour research and therapy. Volume 143(2021)
- Journal:
- Behaviour research and therapy
- Issue:
- Volume 143(2021)
- Issue Display:
- Volume 143, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 143
- Issue:
- 2021
- Issue Sort Value:
- 2021-0143-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-08
- Subjects:
- Obsessive-compulsive disorder -- OCD -- Exposure and ritual prevention -- EX/RP -- Cognitive-behavioral therapy -- CBT
Cognitive therapy -- Periodicals
Psychotherapy -- Periodicals
616.891 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00057967 ↗
http://www.elsevier.com/wps/find/journaldescription.cws_home/265/description#description ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.brat.2021.103890 ↗
- Languages:
- English
- ISSNs:
- 0005-7967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1876.810000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17253.xml